LFCR Earnings

Quarterly EPS
$-0.23
Q4 2024
$-0.53
Q2 2025
$-0.47
Q3 2025
$-0.42
Q4 2025
$-0.06
Q1 2025
$-0.29
Q2 2026
$-0.43
Q4 2026
$-0.19
Q1 2027
Latest Revenue34.2M
Latest Net Income-6156000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.1934.2M-6156000-2.8%+54.8%
Q4 2026-$0.4323.2M-14980000-34.0%+8.5%
Q2 2026-$0.2931.1M-9991000+25.9%+45.3%
Q1 2025-$0.0636.4M-1147000-3.8%+73.9%
Q4 2025-$0.4235.2M-14769000-1.5%-182.4%
Q3 2025-$0.4735.2M-14769000+16.6%-200.0%
Q2 2025-$0.5324.7M-16230000+0.7%-51.4%
Q4 2024-$0.2337.9M-7083000+21.6%+82.3%
Q3 2024$0.5135.7M15.6M
Q2 2024$0.4730.1M14.2M
Q1 2024-$0.3524.5M-10754000
Q4 2023-$1.3031.1M-39284000
Lifecore Biomedical (LFCR) — Earnings